Market Outlook and Growth TrajectoryThe global next generation sequencing market is poised to experience robust expansion, registering an estimated growth rate of around 15% over the next five years.
Metagenomic next‐generation sequencing (mNGS) is revolutionising infectious disease diagnosis by enabling an unbiased interrogation of all genetic material within a clinical sample. This approach ...
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company ™, and ...